Monica Hermann
Overview
Explore the profile of Monica Hermann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
338
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Larsen A, Hermann M, Graue M
Pilot Feasibility Stud
. 2021 Jan;
7(1):12.
PMID: 33407924
Background: Hypoglycemic incidents in older people can cause severe health problems, enhance general age-related disabilities, and cause frailty. Little is known about incidences of hypoglycemia in older home-dwelling people with...
12.
Fjell A, Cronfalk Seiger B, Hermann M, Rongve A, Assmus J, Kvinge L, et al.
BMC Geriatr
. 2020 Sep;
20(1):323.
PMID: 32887555
Background: Assessing self-rated health by preventive home visits of older people can provide information about the person's well-being, quality of life and risk of developing illness. The aim of this...
13.
Tveit K, Hermann M, Waade R, Nilsen R, Wallerstedt S, Molden E
Drugs Aging
. 2020 Jul;
37(9):691-701.
PMID: 32691329
Background: According to previous studies, older patients frequently have serum concentrations of antidepressant medication above the recommended reference range. Objective: The aim of this study was to investigate whether prescribed...
14.
Hove O, Biringer E, Havik O, Assmus J, Braatveit K, Holm S, et al.
Pharmacoepidemiol Drug Saf
. 2019 Feb;
28(3):337-344.
PMID: 30747466
Purpose: Individuals with intellectual disabilities (IDs) have more health problems, a poorer general health, and a shorter life expectancy than individuals in general. High rates of drug use in IDs...
15.
Krogstad V, Vethe N, Robertsen I, Hasvold G, Ose A, Hermann M, et al.
Ther Drug Monit
. 2018 Mar;
40(3):292-300.
PMID: 29578937
Background: Tacrolimus (TAC) is currently the cornerstone of immunosuppressive protocols for renal transplant recipients. Despite therapeutic whole blood monitoring, TAC is associated with nephrotoxicity, and it has been hypothesized that...
16.
Egeland E, Storset E, Robertsen I, Hermann M, Midtvedt K, Theie Gustavsen M, et al.
Transplantation
. 2017 Sep;
102(1):e43-e44.
PMID: 28957846
No abstract available.
17.
Egeland E, Robertsen I, Hermann M, Midtvedt K, Storset E, Theie Gustavsen M, et al.
Transplantation
. 2017 Apr;
101(8):e273-e279.
PMID: 28452920
Background: Patients with high tacrolimus clearance eliminate more drug within a dose interval compared with those with low clearance. Delays in dosing time will result in transient periods of lower...
18.
Waade R, Molden E, Martinsen M, Hermann M, Ranhoff A
Br J Clin Pharmacol
. 2017 Mar;
83(7):1397-1404.
PMID: 28268245
Aims: To determine use of psychotropic drugs and weak opioids in hip fracture patients by analysing plasma samples at admission, and compare detected drug frequencies with prescription registry data and...
19.
Hermann M, Waade R, Molden E
Ther Drug Monit
. 2015 Jan;
37(4):546-9.
PMID: 25565671
Background: Elderly patients are at increased risk for elevated serum concentrations from treatment with selective serotonin reuptake inhibitors (SSRIs). The aim of this study was to examine the use of...
20.
Bakken G, Molden E, Hermann M
Ther Drug Monit
. 2014 Sep;
37(2):256-61.
PMID: 25254417
Background: To investigate the impact of genetic variability in CYP2D6, CYP3A5, and ABCB1 on steady-state serum concentrations of quetiapine and the active metabolite, N-desalkylquetiapine, in psychiatric patients. Methods: Measured serum...